Tianhong Xie

Chinese Academy Of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory Of Vaccine Research And Development On Severe Infectious Diseases
Kunming, 650118, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.

Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.

Journal: Signal transduction and targeted therapy

Published: January 23, 2022

Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells.

Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells.

Journal: Journal of medical virology

Published: November 29, 2021

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.

Journal: Emerging microbes & infections

Published: October 20, 2021

A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.

A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.

Journal: Journal of medical virology

Published: August 23, 2021

Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.

Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 31, 2021

Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.

Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.

Journal: Vaccine

Published: February 28, 2021

Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys.

Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys.

Journal: Emerging microbes & infections

Published: September 15, 2020

N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.

N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.

Journal: Journal of medical virology

Published: August 21, 2020

A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.

A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.

Journal: Virology

Published: April 08, 2020

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.

Journal: Human vaccines & immunotherapeutics

Published: March 12, 2020

PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils.

PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils.

Journal: PloS one

Published: May 28, 2019

CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Journal: PloS one

Published: May 11, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026